Serial Number | 97978222 |
Word Mark | ALLUCENT |
Filing Date | Wednesday, April 20, 2022 |
Status | 700 - REGISTERED |
Status Date | Tuesday, July 30, 2024 |
Registration Number | 7464174 |
Registration Date | Tuesday, July 30, 2024 |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, September 5, 2023 |
Goods and Services | Training and development in the field of conducting clinical trials, namely, conducting tutorials, seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting tutorials, seminars and workshops in the field of software support |
Description of Mark | The mark consists of the word ALLUCENT appearing dark blue with the inside space of the capital letter "A" filled in with an orange triangle in the top half of the "A" that extends between the two outside lines of the "A" and a gold trapezoid in the bottom half of the "A" and the remaining letters appearing in dark blue lowercase. |
Indication of Colors claimed | The color(s) dark blue, orange and gold is/are claimed as a feature of the mark. |
Goods and Services | Data management, namely, abstraction services in the nature of extracting and summarizing information from clinical trial records and collection of medical data from clinical tests and records for business purposes; Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries; Data management, namely, the management for others of databases of patient health data |
Goods and Services | Development of regulatory compliance strategies in the field of medical research, namely, regulatory compliance consulting in the field of drug, biologic, cosmetic and medical device development |
Goods and Services | Cloud computing featuring software that allows users to collect, review, analyze and report on clinical research; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software for providing telehealth, telemedicine, remote care and virtual health care services to patients; cloud computing featuring software that allows users to collect, track, retrieve, validate, summarize, statistically analyze and present data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; Cloud computing featuring software to aggregate, integrate, transfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; Cloud computing featuring software that provides integrated workflows, analytics, visualizations, and reporting features to deliver, process, analyze, elevate, and display patient-generated health data; Cloud computing featuring software that integrates remotely collected health data into databases, systems, platforms, applications, and software that inform clinical research, remote monitoring, and care management; technical consulting services, namely, evaluating the safety of pharmaceutical, medical, cosmetic and consumer devices and products in clinical development or in commercial production; Consulting services for others in the fields of design, planning, implementation and project management of clinical trials; Scientific analysis of statistical and qualitative data relating to clinical trials for pharmaceuticals, biotechnology, medical devices and diagnostics for scientific research and for the development of pharmaceutical, biotechnology, medical device and diagnostic products and methods of use of such devices and products |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, April 26, 2022 |
Primary Code | 035 |
First Use Anywhere Date | Sunday, May 1, 2022 |
First Use In Commerce Date | Sunday, May 1, 2022 |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, April 26, 2022 |
Primary Code | 041 |
First Use Anywhere Date | Sunday, May 1, 2022 |
First Use In Commerce Date | Sunday, May 1, 2022 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, April 26, 2022 |
Primary Code | 042 |
First Use Anywhere Date | Sunday, May 1, 2022 |
First Use In Commerce Date | Sunday, May 1, 2022 |
International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, April 26, 2022 |
Primary Code | 045 |
First Use Anywhere Date | Sunday, May 1, 2022 |
First Use In Commerce Date | Sunday, May 1, 2022 |
Party Name | Clinical Services Corporate Operations, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Cary, NC 27513 |
Party Name | Clinical Services Corporate Operations, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Cary, NC 27513 |
Party Name | Clinical Services Corporate Operations, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Waltham, MA 02452 |
Event Date | Event Description |
Saturday, April 23, 2022 | NEW APPLICATION ENTERED |
Monday, November 21, 2022 | LETTER OF PROTEST EVIDENCE FORWARDED |
Wednesday, January 4, 2023 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |
Friday, January 6, 2023 | NON-FINAL ACTION E-MAILED |
Thursday, April 6, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, April 6, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, April 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, April 27, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Wednesday, December 28, 2022 | ASSIGNED TO EXAMINER |
Friday, January 6, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, January 6, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, April 6, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, May 16, 2023 | FINAL REFUSAL WRITTEN |
Tuesday, May 16, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, June 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, June 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, July 3, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, July 13, 2023 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Thursday, July 13, 2023 | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST |
Saturday, July 29, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Saturday, July 29, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Saturday, July 29, 2023 | EXAMINERS AMENDMENT E-MAILED |
Saturday, July 29, 2023 | EXAMINER'S AMENDMENT ENTERED |
Saturday, July 29, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, August 16, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 5, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, September 5, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, October 31, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, March 26, 2024 | SOU EXTENSION 1 GRANTED |
Tuesday, March 26, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, March 26, 2024 | SOU EXTENSION 1 FILED |
Wednesday, March 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, April 4, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, April 4, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, April 4, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, April 4, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Thursday, April 11, 2024 | DIVISIONAL REQUEST RECEIVED |
Thursday, April 11, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Thursday, April 11, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, April 11, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, April 11, 2024 | TEAS STATEMENT OF USE RECEIVED |
Thursday, April 11, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
Thursday, May 2, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Tuesday, May 16, 2023 | FINAL REFUSAL E-MAILED |
Wednesday, June 21, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Thursday, April 11, 2024 | USE AMENDMENT FILED |
Tuesday, May 21, 2024 | DIVISIONAL PROCESSING COMPLETE |
Tuesday, May 21, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
Tuesday, June 25, 2024 | ASSIGNED TO EXAMINER |
Tuesday, June 25, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Tuesday, June 25, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Tuesday, July 30, 2024 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, July 30, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |